TIGIDANKAY KAMARA: Open Payments
NPI 1851750004 · MCKINNEY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$430 in 11 payments from 7 companies in 2025. Trend: 2023 $194 · 2024 $155 · 2025 $430
Food & beverage: $430
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $155 |
| ABBVIE INC. | 1 | $87 |
| Neurocrine BioSciences, Inc. | 2 | $66 |
| Teva Pharmaceuticals USA, Inc. | 2 | $58 |
| Luye Pharma (USA) Ltd. | 1 | $29 |
| Tris Pharma Inc | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
Products named: COBENFY, VRAYLAR, INGREZZA, UZEDY, ERZOFRI EXTENDED-RELEASE, Dyanavel XR, INVEGA SUSTENNA.
Industry payments across TX — which companies pay providers there.
